Intervention Review

Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia

  1. Alessandro Squizzato1,*,
  2. Erica Romualdi2,
  3. Saskia Middeldorp3

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 15 JAN 2008

DOI: 10.1002/14651858.CD006503.pub2

How to Cite

Squizzato A, Romualdi E, Middeldorp S. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006503. DOI: 10.1002/14651858.CD006503.pub2.

Author Information

  1. 1

    University of Insubria, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical Medicine, Varese, Italy

  2. 2

    University of Insubria, Department of Clinical Medicine, Varese, Italy

  3. 3

    Academic Medical Center, Department of Vascular Medicine, Amsterdam, Netherlands

*Alessandro Squizzato, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Medicina 1, viale Borri, 57, Varese, 21100, Italy. alexsquizzo@libero.it. alessandro.squizzato@uninsubria.it.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia

    Alessandro Squizzato, Erica Romualdi and Saskia Middeldorp

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD006503.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Antiplatelet drugs for polycythemia vera and essential thrombocythaemia

    A Squizzato, E Romualdi and S Middeldorp

    Article first published online: 23 JAN 2008 | DOI: 10.1002/14651858.CD006503